I wish I could like AptarGroup's (NYSE:ATR) stock as much as I like the business. After all, there's something to be said for a company that has leveraged its expertise in valves, pumps and closures to become a leading player in products like fine-mist spray pumps, lotion pumps, nasal spray pumps and a variety of innovative food and beverage packages. Unfortunately, it looks like the Street is already well acquainted with the good points of this company, and the stock sports a fairly demanding valuation.
Investopedia Broker Guide: Enhance your trading with the tools from today's top online brokers.
Personal Care Taking a Powder
When companies such as Unilever (NYSE:UL) and Beiersdorf (OTC:BDRFF) need pumps for personal care products like Axe Body Spray or Nivea lotion, they look to AptarGroup. As a result, this company holds the first or second market share spot in product categories like fine-mist spray pumps and lotion pumps. Although there is competition from a host of private companies and some public companies like MeadWestvaco (NYSE:MWV), product design is important, and consumer companies have to carefully balance the merits of saving a few pennies per unit with alienating customers through inferior products.
These aren't great times for AptarGroup's home and beauty business. More than half of its business comes from Europe, and tougher conditions there and in the United States have led to lower consumer spending (and to consumers trading down in the market for cheaper goods). From 3% core growth in the first quarter, performance slid to basically flat results in the second quarter and it would seem optimistic to hope for a major rebound this year.
Pharmaceuticals are the Crown Jewels
While various pharmaceutical products (especially nasal spray pumps and metered-dose inhalers) comprise about one-quarter of the company's sales, they make up more than half of the company's profits. AptarGroup has extensive IP in this business, as well as clean-room facilities in several countries. Drug companies are loathe to change product packaging for approved prescription drugs (as it can create complications with the FDA), and many generic and OTC manufacturers work with AptarGroup once the prescription drugs go off patent.
While MeadWestvaco and West Pharmaceutical Services (NYSE:WST) offer some competition, this is a large addressable market. Perhaps one of the biggest questions for management is whether they want to broaden their offerings - going beyond pumps and inhalers and perhaps into some of the injector pen products sold by companies like Becton Dickinson (NYSE:BDX).
As has been the case in the personal care business, sales growth has been petering out this year. Worse yet, acquisitions and new plant openings have been leading to some margin compression - while the adjusted segment operating margin of over 27% in the second quarter is still quite good, count on investors to watch this number carefully over the next couple of quarters.
SEE: Things You Didn't Know You Could Copyright
Food And Beverages still a Growth Opportunity
Although food and beverage companies don't generally sport the same margins as drug or personal care companies, there's still a strong market opportunity for innovative packaging products in the food and beverage market. AptarGroup has, for example, designed a new ketchup squeeze bottle for Heinz (NYSE:HNZ), a custom closure for PepsiCo's (NYSE:PEP) Tropicana and the packaging for Kraft's (Nasdaq:KRFT) MiO drink mix. While Bemis (NYSE:BMS) and Sealed Air (NYSE:SEE) are significant competitors in many food categories, there are relatively few others that address as many markets as AptarGroup (particularly in those segments with higher barriers).
SEE: Groceries You're Wasting Your Money On
Can The Company Do Better?
AptarGroup has a pretty solid record of generating mid-single digit organic revenue growth and sharing its success with shareholders through dividends and buybacks. Moreover, the balance sheet is in relatively solid shape.
Unfortunately, some of the company's financials are less impressive. The company is certainly targeting growth opportunities in emerging markets, but more than 80% of the company's business is currently in the mature European and North American markets. Worse still, the company's free cash flow conversion has been sub-standard for most of the past decade due in large part to higher capex and working capital needs.
SEE: Free Cash Flow: Free, But Not Always Easy
The Bottom Line
Better free cash flow conversion would indeed be good news for shareholders, and it should be possible as the company starts leveraging past investments. That said, analysts and investors have already baked in quite a bit of future improvement.
If AptaGroup can deliver 8% free cash flow growth over the next decade, the stock is pretty significantly overvalued today and even a low-teens growth estimate doesn't produce a compelling fair value. Consequently, while I believe AptarGroup will continue to enjoy an economic moat and post solid results, I worry that expectations are already ahead of the stock. This would be a good name to consider on a pullback, but the valuation simply seems too rich today.
At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.
InvestingHow do bond exchange traded fund (ETF) distributions work? It’s a question I get a lot. First, let’s explain what we mean by distributions.
Stock AnalysisThese three stocks are resilient, fundamentally sound and also pay generous dividends.
Investing NewsAre stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
Investing NewsHere are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
Investing NewsHere are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
Stock AnalysisIf you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
Mutual Funds & ETFsExplore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
Mutual Funds & ETFsLearn about arbitrage funds and how this type of investment generates profits by taking advantage of price differentials between the cash and futures markets.
Investing NewsWill Ferrari's shares move fast off the line only to sputter later?
Stock AnalysisHere are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>